A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 136 participants.
Also called NCT02641652
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 136 participants
- Registry
-
NCT02641652
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02641652. Randomized; quadruple masking; primary purpose treatment. Start 2017-11 (anticipated); primary completion 2018-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Controlled Trial of Sertraline in Paroxysmal Arterial Hypertension
- Acronym
- ATRAX
- Condition
- Hypertension
- Intervention (Drug)
- Sertraline
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Hospital Olomouc
- Collaborator
- Brno University Hospital
- Collaborator
- St. Anne
- Collaborator
- University Hospital Ostrava
- Collaborator
- Tomas Bata Hospital, Czech Republic
- Collaborator
- Prerov Hospital
- Collaborator
- Valasske Mezirici Hospital
- Collaborator
- Thomayer University Hospital
- Collaborator
- Vsetin Hospital
Record details
- Record id
cardio:ct-nct02641652- Content hash
b16dad58b206d518a1be576457f4a77e119aeda03c4f778909d3b7b8c936245c